Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunity Persistence After Abridged Intradermal Rabies PEP

NCT04829630 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.

NCT NCT04829630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04829630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunity Persistence After Abridged Intradermal Rabies PEP
Lead sponsor
Institut Pasteur
Phase
Not applicable
Overall status
Completed
Start date
October 20, 2021
Completion date
February 1, 2023
Enrollment
180 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rabies